Date Filed | Type | Description |
08/23/2023 |
8-K
| Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm... |
08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/02/2023 |
8-K
| Appointed a new director |
08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/01/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/20/2023 |
8-K
| Quarterly results |
06/06/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
06/06/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
06/06/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
04/27/2023 |
10-K/A
| Annual Report for the period ended December 31, 2022 [amend] |
03/20/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
03/20/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
03/20/2023 |
8-K
| Quarterly results |
03/16/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
02/23/2023 |
4
| Young Alethia (CFO) has filed a Form 4 on Graphite Bio, Inc.
Txns:
| Granted 220,000 options to buy
@ $2.18, valued at
$479.6k
|
|
02/23/2023 |
4
| Lehrer-Graiwer Joshua (PRESIDENT AND CEO) has filed a Form 4 on Graphite Bio, Inc.
Txns:
| Granted 600,000 options to buy
@ $2.18, valued at
$1.3M
|
|
02/22/2023 |
8-K
| Quarterly results |
02/14/2023 |
SC 13G/A
| Samsara BioCapital, L.P. reports a 14.6% stake in Graphite Bio, Inc. |
01/09/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 14.7% stake in Graphite Bio, Inc. |
01/06/2023 |
3
| EcoR1 Capital, LLC (10% Owner) has filed a Form 3 on Graphite Bio, Inc. |
01/05/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
12/12/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
11/18/2022 |
SC 13G
| EcoR1 Capital, LLC reports a 9.8% stake in Graphite Bio, Inc. |
11/09/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
|